Basit öğe kaydını göster

dc.contributor.authorHindilerden, Fehmi
dc.contributor.authorKucukkaya, Reyhan Diz
dc.contributor.authorHindilerden, Ipek Yonal
dc.date.accessioned2021-12-10T12:39:42Z
dc.date.available2021-12-10T12:39:42Z
dc.date.issued2021
dc.identifier.citationHindilerden F., Hindilerden I. Y. , Kucukkaya R. D. , "Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection", BALKAN MEDICAL JOURNAL, cilt.38, sa.2, ss.141-142, 2021
dc.identifier.issn2146-3123
dc.identifier.othervv_1032021
dc.identifier.otherav_cd26e567-c413-4806-a2b1-3df0780de833
dc.identifier.urihttp://hdl.handle.net/20.500.12627/174355
dc.identifier.urihttps://doi.org/10.4274/balkanmedj.galenos.2020.2020.9.106
dc.language.isoeng
dc.subjectFundamentals and Skills
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectHealth Sciences
dc.subjectTemel Tıp Bilimleri
dc.subjectFamily Practice
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleRapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection
dc.typeMakale
dc.relation.journalBALKAN MEDICAL JOURNAL
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume38
dc.identifier.issue2
dc.identifier.startpage141
dc.identifier.endpage142
dc.contributor.firstauthorID2615985


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster